Clinical Trial Update: Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This trial update reports the completion of a Phase 2 study evaluating the combination of anastrozole and gefitinib (ZD 1839) in postmenopausal women with metas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Iressa (gefitinib)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED